Analysis of FCE 23762 (methoxymorpholinodoxorubicin hydrochloride), a new antitumour agent, by HPTLC and scanning densitometry
Authors:
- 31 December 1993
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 11 (11-12) , 1215-1218
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Determination of 3'-deamino-3'-[2(S)-methoxy-4-morpholinyl]doxorubicin, a new morpholinyl anthracycline, in plasma by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cellsBritish Journal of Cancer, 1992
- Analysis of iododoxorubicin and its major impurityJournal of Pharmaceutical and Biomedical Analysis, 1991
- High-performance liquid chromatography of iodo-doxorubicin and fluorescent metabolites in plasma samplesJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- Assay and purity control of oxytetracycline and doxycycline by thin-layer chromatography — a comparison with liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1990
- Novel anthracycline analogsCancer Treatment Reviews, 1990
- Studies of iododoxorubicin by HPLCJournal of Pharmaceutical and Biomedical Analysis, 1989
- High-performance liquid chromatography of anthracycline antibiotics with electrochemical detection. Application to the clinical pharmacokinetics of 4′-deoxydoxorubicinJournal of Pharmaceutical and Biomedical Analysis, 1987
- High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivativeJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Liquid chromatogrphic determination of daunorubicin and daunorubicinol in plasma from leukemic patientsJournal of Chromatography A, 1978